HIGHLIGHTS
- who: MDPI from the Department of Oncology, Xijing Hospital of Air Force Military Medical University, Xi`an, China have published the research: Type of the Paper (Article, in the Journal: (JOURNAL) of 22/06/2022
- what: The authors report on a locally advanced ascending colon cancer case with a history of incomplete intestinal obstruction which achieved a pathologic (pCR) after treated with as NIT. In the present case, the authors show the feasibility, efficacy, and safety of tirelizumab as a mono-ICI for an optional neoadjuvant therapy in treatment-naive MSI-H/dMMR LACRC patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.